GeneGo and XB TransMed Provide Integrated Solutions to the Translational Medicine Market
Complete the form below to unlock access to ALL audio articles.
GeneGo, Inc. and XB TransMed Solutions have announced that their flagship products, MetaCore™ and XB-BioIntegration Suite (XB-BIS) are fully integrated.
Mutual customers can capture, manage and mine integrated clinical, preclinical and molecular data in its various forms and statistically analyze data associations using XB-BIS, and functionally analyze the associated results in the context of biological pathways, networks, cellular processes and disease networks in MetaCore™.
"XB-BIS has been developed to fulfill the need in translational medicine for efficient data capture, management, analysis and reporting in an intuitive workflow that resembles the natural translational path from early hypothesis generation to validation and application in the areas of clinical diagnostics and intervention," said Dr. Craig Webb, Program Director for Translational Medicine at the Van Andel Institute.
"Integration with the MetaCore™ systems biology toolsets permits the user to seamlessly integrate back and forth between expanding knowledge and enhanced application."
"Over the past year, we have seen an increasing demand in systems biology solutions from the clinical trial market," said Julie Bryant, Vice President of Business Development at GeneGo.
"Understanding the differences of drug effects on individual patients is a very challenging task, which requires state of the art tools in both translational medicine and functional data mining."
"We are very pleased to join forces with XenoBase inventors Dr Craig Webb and Dr. Jeremy Miller at the Van Andel Institute to develop analytical workflows for the clinical environment."
